The Patent Finder
OT

Osiris Therapeutics, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

33 patents currently held

3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.

The next term ends in Jan 2031. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2031
Next term end
15
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Immunocompatible Amniotic Membrane Products US 10,272,116
Cited by 31 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2031.
Ends Jul 2031 · High confidence
Also notable
Methods of Manufacture of Therapeutic Products Comprising Vitalized Placental Dispersions US 9,956,248
Cited by 45 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Ends Feb 2031 · High confidence
Also notable
Immunocompatible Chorionic Membrane Products US 11,590,172
Cited by 9 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Ends Feb 2031 · High confidence

Formerly held, still cited

Notable
Cited by 32 later US patents, top 25% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Ends Jan 2027 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Sep 3 to 30, 2027 · next Sep 3
  • 1 fee due Oct 21, 2027
    The maintenance fee for Umbilical Tissue Compositions and Methods of Use (US 10,624,931) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Methods of Manufacture of Therapeutic Products Comprising Vitalized Placental Dispersions (US 10,646,519) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The largest of its 15 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US D776,823Biological Product Support Element
In force
 · High confidence
In forceHigh confidence
US 9,956,248Methods of Manufacture of Therapeutic Products Comprising Vitalized Placental Dispersions
In force
 · High confidence
In forceHigh confidence
US 10,576,104Methods of Manufacture of Immunocompatible Amniotic Membrane Products
In force
 · High confidence
In forceHigh confidence
US 11,207,353Immunocompatible Amniotic Membrane Products
In force
 · High confidence
In forceHigh confidence
US 11,510,947Methods of Manufacture of Immunocompatible Amniotic Membrane Products
In force
 · High confidence
In forceHigh confidence
US 11,590,172Immunocompatible Chorionic Membrane Products
In force
 · High confidence
In forceHigh confidence
US 11,590,173Methods of Manufacture of Therapeutic Products Comprising Vitalized Placental Dispersions
In force
 · High confidence
In forceHigh confidence
US 11,638,725Methods of Manufacture of Immunocompatible Chorionic Membrane Products
In force
 · High confidence
In forceHigh confidence
US 11,986,498Therapeutic Products Comprising Vitalized Placental Dispersions
In force
 · High confidence
In forceHigh confidence
US 12,109,241Methods of Manufacture of Immunocompatible Chorionic Membrane Products
In force
 · High confidence
In forceHigh confidence
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
Also on record, not counted in the 33: 3 patents in force now held by others · 17 patents ended · 20 applications pending · 59 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited